COVID-19 Update | June 26, 2020

COVID-19 News

COVID-19 Update | June 26, 2020

June 26, 2020

The California Biotechnology Foundation is committed to keeping you up to date about COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of June 26, 2020. Notable advancements include:

  • Sanofi is accelerating the development timeline for a COVID-19 vaccine that could yield regulatory approval sometime next year.
  • Gilead will begin clinical studies of an inhaled form of remdesivir to expand the drug’s use to healthier, non-hospitalized COVID-19 patients.
  • Moderna is partnering with Catalent to prepare an initial 100 million doses of its coronavirus vaccine for the United States, starting in the third quarter of this year.

​Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new CABiotech.org

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or patty.cooper@cabiotech.org.